InsidersTradesSigma
Follow the Camurus AB stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Camurus AB has recorded 8 reports. Market capitalisation: €36.6bn. The latest transaction was filed on 10 August 2026 (Sale). Among the most active insiders: Richard Jameson. The full history is accessible without an account.
8
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€720,663
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Camurus AB Strong Buy (bullish), based on 8 analysts. Average price target: SEK 776.75.
15Σ signal
Fundamental score
Ranked 8,197 of 29,064 companies
62.3
score / 100
Value35
Quality90
FCF yld2.1%
Earn yld2.1%
EV/EBITDA36.1x
ROE16%
Gross mgn93%
Net mgn32%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 August 2026
Declarations8 total
5,800 shares@ €48.1476AktieISIN SE0007692850FI:csv-814ed16883072a60f5df
1,000 shares0TeckningsoptionFI:A003S458-2
4,000 shares0AktieISIN SE0007692850FI:A003S567-1
16,000 shares0AktieISIN SE0007692850FI:A003P837-1
16,000 shares0AktieISIN SE0007692850FI:A003P645-1
16,725 shares@ SEK 180.00100.0% of flowAktieISIN SE0007692850FI:A001P414-1
8,000 shares@ SEK 179.28100.0% of flowAktieISIN SE0007692850FI:A001P406-1
43,600 shares0AktieISIN SE0007692850FI:A001P326-1
8 of 8 declarations
关于 Camurus AB
Camurus AB 是一家瑞典制药公司，专注于开发慢性疾病的创新疗法。该公司在斯德哥尔摩证券交易所 (XSTO) 上市。